{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:09:51Z","timestamp":1778620191551,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["02350922"],"award-info":[{"award-number":["02350922"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["5X1000"],"award-info":[{"award-number":["5X1000"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR 2011-12"],"award-info":[{"award-number":["GR 2011-12"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007388","name":"Compagnia di San Paolo","doi-asserted-by":"publisher","award":["2017-0529"],"award-info":[{"award-number":["2017-0529"]}],"id":[{"id":"10.13039\/100007388","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.clbc.2020.09.001","type":"journal-article","created":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T05:51:23Z","timestamp":1599371483000},"page":"218-230.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Radiation-Related Deregulation of TUBB3 and BRCA1\/2 and Risk of Secondary Lung Cancer in Women With Breast Cancer"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5296-4325","authenticated-orcid":false,"given":"Simona","family":"Coco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Boccardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3198-9432","authenticated-orcid":false,"given":"Irene","family":"Vanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3690-8582","authenticated-orcid":false,"given":"Carlo","family":"Genova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9726-201X","authenticated-orcid":false,"given":"Angela","family":"Alama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Giovanna","family":"Dal Bello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Bonfiglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Rijavec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Sini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Barletta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Biello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franca","family":"Carli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2554-8035","authenticated-orcid":false,"given":"Zita","family":"Cavalieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Burrafato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5153-4243","authenticated-orcid":false,"given":"Luca","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Ballestrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Grossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2020.09.001_bib1","first-page":"297","article-title":"Cancer screening in the United States, 2018: a review of current American Cancer Society guidelines and current issues in cancer screening","volume":"68","author":"Smith","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clbc.2020.09.001_bib2","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clbc.2020.09.001_bib3","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/jamaoncol.2015.3084","article-title":"Breast tumor prognostic characteristics and biennial vs annual mammography, age, and menopausal status","volume":"1","author":"Miglioretti","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clbc.2020.09.001_bib4","first-page":"439","article-title":"Breast cancer statistics, 2017, racial disparity in mortality by state","volume":"67","author":"DeSantis","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clbc.2020.09.001_bib5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijrobp.2006.12.011","article-title":"Risk of second malignancies after adjuvant radiotherapy for breast cancer: a large-scale, single-institution review","volume":"68","author":"Kirova","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2020.09.001_bib6","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/S0959-8049(02)00089-8","article-title":"Lung cancer risks in women with previous breast cancer","volume":"38","author":"Prochazka","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clbc.2020.09.001_bib7","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/JTO.0000000000000213","article-title":"Non\u2013small-cell lung cancer after breast cancer: a population-based study of clinicopathologic characteristics and survival outcomes in 3529 women","volume":"9","author":"Milano","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.clbc.2020.09.001_bib8","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jtho.2017.01.021","article-title":"Radiation therapy for invasive breast cancer increases the risk of second primary lung cancer: a nationwide population-based cohort analysis","volume":"12","author":"Huang","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.clbc.2020.09.001_bib9","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/cncr.11655","article-title":"The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06","volume":"98","author":"Deutsch","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2020.09.001_bib10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1200\/JCO.2007.13.3033","article-title":"Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer","volume":"26","author":"Kaufman","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2020.09.001_bib11","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/cncr.11214","article-title":"Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma","volume":"97","author":"Zablotska","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2020.09.001_bib12","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/1055-9965.EPI-10-1325","article-title":"Reproductive and hormonal factors and lung cancer risk in the NIH-AARP Diet and Health Study cohort","volume":"20","author":"Brinton","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clbc.2020.09.001_bib13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.mehy.2010.10.030","article-title":"Gender is a risk factor for lung cancer","volume":"76","author":"Gasperino","year":"2011","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.clbc.2020.09.001_bib14","first-page":"2141","article-title":"Human non\u2013small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen","volume":"62","author":"Stabile","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.clbc.2020.09.001_bib15","doi-asserted-by":"crossref","first-page":"11287","DOI":"10.1158\/0008-5472.CAN-05-2737","article-title":"Aromatase inhibitors in human lung cancer therapy","volume":"65","author":"Weinberg","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.clbc.2020.09.001_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0022-5223(94)70232-2","article-title":"Sex hormone receptors in non\u2013small-cell lung cancer in human beings","volume":"108","author":"Canver","year":"1994","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.clbc.2020.09.001_bib17","doi-asserted-by":"crossref","first-page":"56443","DOI":"10.18632\/oncotarget.16992","article-title":"Estrogen promotes tumor metastasis via estrogen receptor beta-mediated regulation of matrix-metalloproteinase-2 in non\u2013small cell lung cancer","volume":"8","author":"Fan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clbc.2020.09.001_bib18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/1078-0432.CCR-10-0992","article-title":"Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome","volume":"17","author":"Stabile","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2020.09.001_bib19","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","article-title":"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2020.09.001_bib20","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1158\/1078-0432.CCR-11-0761","article-title":"DNA repair: from genome maintenance to biomarker and therapeutic target","volume":"17","author":"Jalal","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2020.09.001_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fgene.2015.00157","article-title":"DNA repair mechanisms in cancer development and therapy","volume":"6","author":"Torgovnick","year":"2015","journal-title":"Front Genet"},{"key":"10.1016\/j.clbc.2020.09.001_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(02)00615-3","article-title":"Cancer susceptibility and the functions of BRCA1 and BRCA2","volume":"108","author":"Venkitaraman","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.clbc.2020.09.001_bib23","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","article-title":"DNA repair by ERCC1 in non\u2013small-cell lung cancer and cisplatin-based adjuvant chemotherapy","volume":"355","author":"Olaussen","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2020.09.001_bib24","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1200\/JCO.2009.21.9766","article-title":"Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non\u2013small-cell lung cancer","volume":"27","author":"Reynolds","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2020.09.001_bib25","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1158\/1535-7163.MCT-05-0244","article-title":"Class III beta-tubulin expression in tumor cells predicts response and outcome in patients with non\u2013small cell lung cancer receiving paclitaxel","volume":"4","author":"S\u00e8ve","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.clbc.2020.09.001_bib26","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/bjc.2011.129","article-title":"Thymidylate synthase as a determinant of pemetrexed sensitivity in non\u2013small cell lung cancer","volume":"104","author":"Takezawa","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2020.09.001_bib27","doi-asserted-by":"crossref","first-page":"302649","DOI":"10.1155\/2015\/302649","article-title":"Expression of ribonucleotide reductase subunit-2 and thymidylate synthase correlates with poor prognosis in patients with resected stages I-III non\u2013small cell lung cancer","volume":"2015","author":"Grossi","year":"2015","journal-title":"Dis Markers"},{"key":"10.1016\/j.clbc.2020.09.001_bib28","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2020.09.001_bib29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5858\/arpa.2013-0953-SA","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update","volume":"138","author":"Wolff","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.clbc.2020.09.001_bib30","first-page":"910","article-title":"Progesterone and estrogen receptor expression and activity in human non\u2013small cell lung cancer","volume":"76","author":"Marquez-Garban","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.clbc.2020.09.001_bib31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.celrep.2018.03.076","article-title":"Genomic and molecular landscape of DNA damage repair deficiency across The Cancer Genome Atlas","volume":"23","author":"Knijnenburg","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.clbc.2020.09.001_bib32","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1200\/JCO.1984.2.10.1102","article-title":"Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer","volume":"2","author":"Clark","year":"1984","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2020.09.001_bib33","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/cncr.25638","article-title":"Lung cancer mortality risk among breast cancer patients treated with anti-estrogens","volume":"117","author":"Bouchardy","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2020.09.001_bib34","first-page":"1121","article-title":"Second primary lung cancers among breast cancer patients treated with anti-estrogens have a longer cancer-specific survival","volume":"35","author":"Hsu","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clbc.2020.09.001_bib35","first-page":"1721","article-title":"The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status","volume":"23","author":"Schonfeld","year":"2012","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clbc.2020.09.001_bib36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/annonc\/mdf039","article-title":"Very young women (< 35 years) with operable breast cancer: features of disease at presentation","volume":"13","author":"Colleoni","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2020.09.001_bib37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.gene.2015.03.061","article-title":"Class III \u03b2-tubulin in normal and cancer tissues","volume":"563","author":"Mariani","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.clbc.2020.09.001_bib38","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.3892\/ol.2016.4206","article-title":"High levels of class III \u03b2-tubulin expression are associated with aggressive tumor features in breast cancer","volume":"11","author":"Lebok","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.clbc.2020.09.001_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.clbc.2012.11.003","article-title":"High expression of class III \u03b2-tubulin predicts good response to neoadjuvant taxane and doxorubicin\/cyclophosphamide-based chemotherapy in estrogen receptor\u2013negative breast cancer","volume":"13","author":"Wang","year":"2013","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2020.09.001_bib40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10549-011-1427-0","article-title":"Prognostic utility of \u03b2-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study 2011","volume":"127","author":"Pentheroudakis","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2020.09.001_bib41","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1158\/1078-0432.CCR-12-1359","article-title":"Biomarker analysis of neoadjuvant doxorubicin\/cyclophosphamide followed by ixabepilone or paclitaxel in early stage breast cancer","volume":"19","author":"Horak","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2020.09.001_bib42","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1349-7006.2004.tb02195.x","article-title":"Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage","volume":"95","author":"Yoshida","year":"2004","journal-title":"Cancer Sci"},{"key":"10.1016\/j.clbc.2020.09.001_bib43","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A\u00a0strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.clbc.2020.09.001_bib44","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/bcr557","article-title":"Regulation of BRCA1 expression and its relationship to sporadic breast cancer","volume":"5","author":"Mueller","year":"2003","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2020.09.001_bib45","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/cancers11040441","article-title":"Integrated somatic and germline whole-exome sequencing analysis in women with lung cancer after a previous breast cancer","volume":"11","author":"Coco","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clbc.2020.09.001_bib46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/35003506","article-title":"A\u00a0ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage","volume":"404","author":"Tanaka","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.clbc.2020.09.001_bib47","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.celrep.2013.03.040","article-title":"Chromosomal instability triggered by Rrm2b loss leads to IL-6 secretion and plasmacytic neoplasms","volume":"3","author":"Chang","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.clbc.2020.09.001_bib48","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1158\/1078-0432.CCR-05-2694","article-title":"Epigenetic inactivation of the chromosomal stability control genes BRCA1, BRCA2, and XRCC5 in non\u2013small cell lung cancer","volume":"13","author":"Lee","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2020.09.001_bib49","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4103\/0973-1482.140985","article-title":"Expression of BRCA1 and BRCA2 proteins and their correlation with clinical staging in breast cancer","volume":"11","author":"Hedau","year":"2015","journal-title":"J\u00a0Cancer Res Ther"},{"key":"10.1016\/j.clbc.2020.09.001_bib50","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrc3181","article-title":"BRCA1 and BRCA2: different roles in a common pathway of genome protection","volume":"12","author":"Roy","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clbc.2020.09.001_bib51","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.3892\/ijo.2014.2614","article-title":"Radiation-induced signaling pathways that promote cancer cell survival","volume":"45","author":"Hein","year":"2014","journal-title":"Int J Oncol"},{"key":"10.1016\/j.clbc.2020.09.001_bib52","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41419-018-0652-4","article-title":"FoxM1-dependent RAD51 and BRCA2 signaling protects idiopathic pulmonary fibrosis fibroblasts from radiation-induced cell death","volume":"9","author":"Im","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.clbc.2020.09.001_bib53","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.lungcan.2009.09.007","article-title":"The role of betaIII tubulin in predicting chemoresistance in non\u2013small cell lung cancer","volume":"67","author":"S\u00e8ve","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clbc.2020.09.001_bib54","first-page":"1355","article-title":"Fenretinide-induced neuronal differentiation of ARPE-19 human retinal pigment epithelial cells is associated with the differential expression of Hsp70, 14-3-3, pax-6, tubulin beta-III, NSE, and bag-1 proteins","volume":"12","author":"Chen","year":"2006","journal-title":"Mol Vis"},{"key":"10.1016\/j.clbc.2020.09.001_bib55","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/mc.2940030609","article-title":"Effects of ionizing radiation on expression of genes encoding cytoskeletal elements: kinetics and dose effects","volume":"3","author":"Woloschak","year":"1990","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.clbc.2020.09.001_bib56","doi-asserted-by":"crossref","first-page":"E913","DOI":"10.3390\/cancers11070913","article-title":"Differentiation induction as a response to irradiation in neural stem cells in\u00a0vitro","volume":"11","author":"Kon\u00ed\u0159ov\u00e1","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clbc.2020.09.001_bib57","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41523-017-0050-6","article-title":"Biomarkers of aging associated with past treatments in breast cancer survivors","volume":"3","author":"Scuric","year":"2017","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.clbc.2020.09.001_bib58","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fonc.2018.00427","article-title":"Second primary lung cancer after breast cancer: a population-based study of 6,269 women","volume":"8","author":"Wang","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.clbc.2020.09.001_bib59","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/modpathol.2010.38","article-title":"A\u00a0study of immunohistochemical differential expression in pulmonary and mammary carcinomas","volume":"23","author":"Yang","year":"2010","journal-title":"Mod Pathol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820920302160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820920302160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:14:27Z","timestamp":1778616867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820920302160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1526820920302160"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2020.09.001","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation-Related Deregulation of TUBB3 and BRCA1\/2 and Risk of Secondary Lung Cancer in Women With Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2020.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}